Aduro Biotech, Inc.;Providence Health & Services-Oregon D/b/a Providence Portland Medical Center; Inc.;Aduro Biotech
发明人:
LAUER Peter M.,BAHJAT Keith
申请号：
SI201131548
公开号：
SI2640842T1
申请日:
2011.11.17
申请国别(地区):
SI
年份:
2018
代理人:
摘要：
The present invention relates to methods of inducing a T-cell response against a EGFRvIII in a subject. These method comprise administering to a subject a composition which expresses at least one immunogenic polypeptide, the amino acid sequence of which comprise a plurality of EGFRvIII polypeptide sequences, the sequence of which each comprise EEKKGNYV (SEQ ID NO: 3), and/or administering the polypeptide itself.
